Targeting the Gut Microbiome to Investigate the Pathways of Progression From Obesity to Metabolic Diseases in an At-risk Population.

NCT01433120 · clinicaltrials.gov ↗
NA
Phase
COMPLETED
Status
58
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

University of Copenhagen

Collaborators